Randomized controlled trials do not support efficacy of any of the tested doses of fluvoxamine in prevention of disease progression in adults with incipient non-severe COVID-19 disease: a case-study systematic review and meta-analysis

Related documents

• Plasma proteomics link menopause timing to brain aging and dementia risk#169091
• Congestion-aware pick-up and drop-off network design problem#171128
• Development and utilization of irrigation simulation with CERES-Maize in a central Iowa cornfield#171129
• An investigation into the effect of clinical states of infection on pharmacokinetics and pharmacodynamics in ruminant food animal species#171130
• One dimensional model and pulse generation of a supercharger#171131